Immunoassays Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

The Immunoassays Market: By Product & Service (Reagents and Kits, Analyzers, Software), Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), By Application (Infectious Diseases, Oncology, Cardiology, Endocrinology, Hematology), End User (Hospitals, Diagnostic centers, Blood Banks, Others) By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global Immunoassays Market is projected to reach USD 39.2 billion by 2027 from USD 28.6 billion in 2021, at a CAGR of 6.8% during the forecast period 2021-2027. Immunoassays Market is a test that uses antibodies or immunoglobulin to assess the concentration of a macromolecule in a solution. Analyte refers to the macromolecule that has been detected. For medical and research reasons, immunoassay is used to determine the amount of analytes in serum and urine. An immunoassay is a biochemical test directed in IVD research centers for the identification of essence of particular particles in an answer with the utilization of an antigen or neutralizer. Immunoassay diagnostics tests have been broadly utilized for over 40 years in healing centers, analytic labs, blood donation centers, and research labs. Immunoassays have various applications in vitro diagnostics for the determination of different unending and also irresistible illnesses, forecast of sickness course, surrounding the treatment, and observing the viability of the treatment. Immunoassays are broadly utilized as a part of the existence science industry for concentrate different natural frameworks by methods for examination of various organic particles, for example, proteins, hormones, and antibodies. Rising rates of chronic & infectious disease and utilization of immunoassays in Oncology are the factors moving the development of the world immunoassay advertise. Furthermore, mechanical headways and affectability, cost viability, and quick investigation offered by immunoassays supplement the development. Be that as it may, low location breaking point and execution of extract obligation by the U.S. Government are impeding the development of this market. Extending biotechnology and pharmaceutical enterprises and research center robotization and developing markets in Asia presents huge openings. Improvement of incorporated frameworks with finish mechanization for finding of viral basic changes and new popular scourges are foreseen to show critical open doors in the worldwide immunoassay showcase amid the conjecture time frame. With an ascent in solidification among indicative research facilities, test volumes are anticipated to increment. This is relied upon to support interest for more coordinated multi segment frameworks that can offer arrangements, for example, total computerized test taking care of and post process test stockpiling, information combination with lab mechanization stage, and remote access checking and control. There are couple of frameworks accessible in the market that offer these highlights. One such framework is Siemens Healthineer’s Atellica analyzer framework that was presented in 2016 and gotten FDA endorsement in 2017. Late endorsements from the U.S. FDA reflect expanding speculations from scratch players for the improvement of purpose of-mind mechanized immunoassay analyzer frameworks and the ascent popular from end-users.In September 2017, Meridian Life science Inc. propelled TRUBlock Ultra, which is a functioning immunoassay impedance blocker made by HAMA, rheumatoid factor (RH), and heterophillic antibodies (HA). In June 2017, Qiagen created QFT-Plus, which identifies inert tuberculosis disease got FDA endorsement.

 


Global Immunoassays Market

MARKET SUMMARY
-
6.8%
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 6.8%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Immunoassays Market

  • The Immunoassays Market is classified on the basis of Product & Service, Technology, Application, End User and geographical regions.
  • The rise in chronic illness incidences is a major driver of market growth in the Global Immunoassay industry. Total CVD cases nearly doubled from 271 million in 1990 to 523 million in 2019, with the number of CVD deaths rising from 12.1 million in 1990 to 18.6 million in 2019.
  • Dengue fever is predicted to affect 100-400 million people per year by May 2021. According to the World Health Organization (WHO), an estimated 10 million individuals globally contracted tuberculosis (TB) in 2019.
  • There are 5.6 million men, 3.2 million women, and 1.2 million children in the country. Tuberculosis is seen in all countries and in all age groups. The rising prevalence of various diseases necessitates the development of cost-effective diagnostic methods, resulting in the growth of the Global Immunoassay Market.
  • Another key growth factor is the global increase in the ageing population. In 2019, the United Nations reported that there were 703 million persons aged 65 and up around the world.
  • As a result of the large number of senior populations, many chronic and acute diseases develop, necessitating rapid diagnosis, resulting in a growth in the global Immunoassay Market.
Market Key Players
  • Abbott Laboratories
  • Roche
  • Siemens
  • bioMérieux
  • Sysmex Corporationn
  • Ortho Clinical Diagnostics
  • QIAGEN
  • DiaSorin
  • Thermo Fisher Scientific
  • Merck
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • PerkinElmer
  • Agilent Technologies
  • Bio-Techne Corporation
  • Quidel Corporation
  • Mindray
Growth

Immunoassays Market

The growing number of instances of COVID 19 around the world has necessitated the development of reliable immunoassay kits for testing reasons, resulting in an increase in demand for the global immunoassay market. Furthermore, technological advancements that improve the efficiency of Immunoassay in terms of cost and performance, such as the design of immunochemical approaches that bring advantages seen with larger molecular analytes with small molecules like metabolites and toxins, are driving the market forward. Several developing technologies, including as condition-specific biomarkers and others, as well as a growing geriatric population, are likely to aid the market’s expansion.


North-America Got Significant Share

Immunoassays Market

Geographically Immunoassays Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America rules the immunoassay market attributable to the nearness of significant market players, high selection rate, and expanding commonness of irresistible sicknesses. As per the measurements recommended by the Centers for Disease Control (CDC) and Prevention, around 9,421 instances of tuberculosis, 51,455 instances of salmonella, 33,461 instances of Lyme ailment, and 433 instances of meningococcal ailment were enlisted in the United States. Europe holds the second position in the immunoassay market. It is normal that the financing gave by the legislature and private associations towards innovative work and the rising commonness of irresistible infection are probably going to drive the European market. Owing to an enormous patient pool and the expanding interest and advancement in the human services innovation, Asia Pacific is the quickest developing immunoassay market Medicinal services use is observed to enhance in different districts in the Asia Pacific. As indicated by the information recommended by the Australian Institute of Health and Welfare amid the year 2015– 16, the aggregate wellbeing consumption was USD 170.4 billion, i.e., 3.6% higher than the use of 2014– 2015. The rising instances of bladder tumor are likewise pushing the market development in the Asia Pacific area.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015 to 2020) and forecast (2021 to 2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Immunoassays Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Abbott Laboratories
  • Roche
  • Siemens
  • bioMérieux
  • Sysmex Corporationn
  • Ortho Clinical Diagnostics
  • QIAGEN
  • DiaSorin
  • Thermo Fisher Scientific
  • Merck
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • PerkinElmer
  • Agilent Technologies
  • Bio-Techne Corporation
  • Quidel Corporation
  • Mindray

Description

The global Immunoassays Market is projected to reach USD 39.2 billion by 2027 from USD 28.6 billion in 2021, at a CAGR of 6.8% during the forecast period 2021-2027. Immunoassays Market is a test that uses antibodies or immunoglobulin to assess the concentration of a macromolecule in a solution. Analyte refers to the macromolecule that has been detected. For medical and research reasons, immunoassay is used to determine the amount of analytes in serum and urine. An immunoassay is a biochemical test directed in IVD research centers for the identification of essence of particular particles in an answer with the utilization of an antigen or neutralizer. Immunoassay diagnostics tests have been broadly utilized for over 40 years in healing centers, analytic labs, blood donation centers, and research labs. Immunoassays have various applications in vitro diagnostics for the determination of different unending and also irresistible illnesses, forecast of sickness course, surrounding the treatment, and observing the viability of the treatment. Immunoassays are broadly utilized as a part of the existence science industry for concentrate different natural frameworks by methods for examination of various organic particles, for example, proteins, hormones, and antibodies. Rising rates of chronic & infectious disease and utilization of immunoassays in Oncology are the factors moving the development of the world immunoassay advertise. Furthermore, mechanical headways and affectability, cost viability, and quick investigation offered by immunoassays supplement the development. Be that as it may, low location breaking point and execution of extract obligation by the U.S. Government are impeding the development of this market. Extending biotechnology and pharmaceutical enterprises and research center robotization and developing markets in Asia presents huge openings. Improvement of incorporated frameworks with finish mechanization for finding of viral basic changes and new popular scourges are foreseen to show critical open doors in the worldwide immunoassay showcase amid the conjecture time frame. With an ascent in solidification among indicative research facilities, test volumes are anticipated to increment. This is relied upon to support interest for more coordinated multi segment frameworks that can offer arrangements, for example, total computerized test taking care of and post process test stockpiling, information combination with lab mechanization stage, and remote access checking and control. There are couple of frameworks accessible in the market that offer these highlights. One such framework is Siemens Healthineer’s Atellica analyzer framework that was presented in 2016 and gotten FDA endorsement in 2017. Late endorsements from the U.S. FDA reflect expanding speculations from scratch players for the improvement of purpose of-mind mechanized immunoassay analyzer frameworks and the ascent popular from end-users.In September 2017, Meridian Life science Inc. propelled TRUBlock Ultra, which is a functioning immunoassay impedance blocker made by HAMA, rheumatoid factor (RH), and heterophillic antibodies (HA). In June 2017, Qiagen created QFT-Plus, which identifies inert tuberculosis disease got FDA endorsement.

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX